NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
NASDAQ · LFST · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
LifeStance Health Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.11% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
LifeStance Health Group, Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of $0.04. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow LifeStance Health Group, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 7, 2025 | $0.00+104.63% vs estimate | $332.97M-4.51% vs estimate |
|---|
| Q4 2024 | Feb 27, 2025 | -$0.02+50.0% vs estimate | $325.50M+3.67% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | -$0.02+71.43% vs estimate | $312.72M-0.4% vs estimate |
|---|
THE ANALYST VIEW
11 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 7 contributors · Median target $15.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$275.20+$4.16 (+1.53%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.09% below the high.
$60.22+$0.76 (+1.28%)
BrightSpring Health Services, Inc. Common Stock’s quoted price sits in the upper half of its reported 52-week range, 18.35% below the high.
$176.61+$4.43 (+2.57%)
Universal Health Services, Inc.’s quoted price sits in the lower half of its reported 52-week range, 28.3% below the high.
$29.67+$0.35 (+1.19%)
Hims & Hers Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.62% below the high.
$22.00+$0.16 (+0.71%)
Privia Health Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.68% below the high.
$29.46-$0.05 (-0.17%)
Acadia Healthcare Company, Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.78% below the high.
$2.32+$0.09 (+4.04%)
LifeMD, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.9% below the high.
